BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8171642)

  • 21. Immunomodulation with ionizing radiation does not prolong fish-to-mouse islet xenograft survival.
    Yang H; Kearns H; Wright JR
    Transplant Proc; 1995 Dec; 27(6):3312-3. PubMed ID: 8539966
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolongation of islet allograft survival following immunologic conditioning by antigen-feeding in the pig.
    Hrstka J; Hesse UJ; Hrstka V; Danis J; Schmitz-Rode M; Tunggal B; Hördegen P; Peters S
    Transplant Proc; 1992 Apr; 24(2):663-4. PubMed ID: 1566472
    [No Abstract]   [Full Text] [Related]  

  • 23. Improvement in allograft survival of islets of Langerhans by pretreatment with deoxyguanosine.
    al-Abdullah IH; Kumar MS; al-Adnani MS; Abouna GM
    Diabetes Res; 1991 Aug; 17(4):181-7. PubMed ID: 1823639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolongation of allograft survival with Ling Zhi-8, a new immunosuppressive drug.
    van der Hem LG; van der Vliet JA; Bocken CF; Kino K; Hoitsma AJ; Tax WJ
    Transplant Proc; 1994 Apr; 26(2):746. PubMed ID: 8171639
    [No Abstract]   [Full Text] [Related]  

  • 25. Islet xenografts in mice and rats: I. Exocrine tissue is detrimental to engraftment and survival of human islet xenografts.
    Nicolae M; Ketchum RJ; Jahr H; Janoff H; Brayman KL
    Transplant Proc; 1994 Apr; 26(2):774. PubMed ID: 8171657
    [No Abstract]   [Full Text] [Related]  

  • 26. Fifty islets maintain euglycemia and survive longer than 200 islets in allogeneic and xenogeneic diabetic hosts.
    Ohzato H; Porter J; Monaco AP; Maki T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):953-4. PubMed ID: 8442277
    [No Abstract]   [Full Text] [Related]  

  • 27. Augmented survival of purified islet xeno- and allografts with reduced numbers.
    Gotoh M; Maki T; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):984. PubMed ID: 3152654
    [No Abstract]   [Full Text] [Related]  

  • 28. Isolation of functional MHC class I-deficient islet cells.
    Osorio RW; Ascher NL; Jaenisch R; Natuzzi ES; Freise CE; Roberts JP; Stock PG
    Transplant Proc; 1993 Feb; 25(1 Pt 2):968-9. PubMed ID: 8442283
    [No Abstract]   [Full Text] [Related]  

  • 29. Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen.
    Osorio RW; Ascher NL; Stock PG
    Transplantation; 1994 Mar; 57(6):783-8. PubMed ID: 8154021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allograft of microencapsulated islets in agarose gel in streptozotocin-induced and nonobese diabetic mice.
    Iwata H; Takagi T; Yamashita K; Kobayashi K; Amemiya H
    Transplant Proc; 1992 Jun; 24(3):997. PubMed ID: 1604705
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental xenotransplantation using principal islets of teleost fish (Brockmann Bodies): graft survival in selected strains of inbred mice.
    Wright JR; Kearns H; Polvi S; MacLean H; Yang H
    Transplant Proc; 1994 Apr; 26(2):770. PubMed ID: 8171655
    [No Abstract]   [Full Text] [Related]  

  • 32. Microencapsulated transplantation of allogeneic islets into specifically presensitized recipients.
    Siebers U; Zekorn T; Horcher A; Klöck G; Houben R; Frank H; Bretzel RG; Zimmermann U; Federlin K
    Transplant Proc; 1994 Apr; 26(2):787-8. PubMed ID: 8171662
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of immune system stimulation on encapsulated islet graft survival.
    Orłowski TM; Godlewska E; Tarchalska M; Kinasiewicz J; Antosiak M; Sabat M
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):180-4. PubMed ID: 15928588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leflunomide and cyclosporin-A prolong fish-to-mouse islet xenograft survival in BALB/C mice.
    Wright JR; Kearns H; McDonald AS
    Transplant Proc; 1994 Jun; 26(3):1310. PubMed ID: 8029918
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies of privileged sites and islet transplantation.
    Barker CF; Markmann JF; Posselt AM; Naji A
    Transplant Proc; 1991 Aug; 23(4):2138-42. PubMed ID: 1871831
    [No Abstract]   [Full Text] [Related]  

  • 36. Potent immunosuppressive effect of anti-LFA-1 monoclonal antibody on islet allograft rejection.
    Nishihara M; Gotoh M; Fukuzaki T; Ohta Y; Monden M; Yagita H; Okumura K; Miyasaka M; Mori T
    Transplant Proc; 1995 Feb; 27(1):372. PubMed ID: 7879025
    [No Abstract]   [Full Text] [Related]  

  • 37. Induction of unresponsiveness to islet allograft by anti-LFA-1 monoclonal antibody treatment.
    Gotoh M; Fukuzaki T; Dono K; Wada H; Kanai T; Monden M; Yagita H; Okumura K; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):973-4. PubMed ID: 8442286
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo function of pig islet xenografts in immunosuppressed diabetic mice.
    Tai J; Cheung SS; Tsang A; Tze WJ
    Transplant Proc; 1995 Dec; 27(6):3316-7. PubMed ID: 8539968
    [No Abstract]   [Full Text] [Related]  

  • 39. Acceptance of donor-specific islet allografts in rat by intraportal preimmunization with islets and FK 506.
    Yasunami Y; Ryu S; Ueki M; Arima T; Ikeda S; Kamei T
    Transplant Proc; 1994 Apr; 26(2):722. PubMed ID: 7513467
    [No Abstract]   [Full Text] [Related]  

  • 40. Prolonged islet allograft survival by alpha-1 antitrypsin: the role of humoral immunity.
    Molano RD; Pileggi A; Song S; Zahr E; San Jose S; Molina J; Fort A; Wasserfall C; Ricordi C; Atkinson MA; Inverardi L
    Transplant Proc; 2008 Mar; 40(2):455-6. PubMed ID: 18374099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.